Skip to content

Ionis Pharmaceuticals IONS Ionis Operations — Segment Reporting Other Item Amount

Similar metrics at other companies

Incyte logo
INCYReportable Segment — Other segment items
-$2.21M-105%
Aptiv logo
APTVIntelligent Systems — Segment Reporting, Other Segment Item, Amount
$5M-37.5%
JB Hunt Transport Services logo
JBHTICS — Segment Reporting Other Item Amount
$100K-50.0%
Roivant Sciences logo
ROIVReportable Segment — Other Nonoperating Income (Expense)
$12.57M+542%
Corvex
 logo
MOVESegment Reporting — Segment Reporting Other Item Amount
$1.42M
Insmed logo
INSMReportable Segment — Other segment items
$210.49M+75.9%

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's ionis operations — segment reporting other item amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's ionis operations — segment reporting other item amount?
Ionis Pharmaceuticals (IONS) reported ionis operations — segment reporting other item amount of $18.38M in Q1 2026.
How has Ionis Pharmaceuticals's ionis operations — segment reporting other item amount changed year-over-year?
Ionis Pharmaceuticals's ionis operations — segment reporting other item amount decreased by 38.3% year-over-year, from $29.8M to $18.38M.
What is the long-term trend for Ionis Pharmaceuticals's ionis operations — segment reporting other item amount?
Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — segment reporting other item amount has grown at a 49.2% compound annual growth rate (CAGR), from -$40.21M to $133.58M.
What does ionis operations — segment reporting other item amount mean?
Miscellaneous or non-recurring costs and adjustments specific to the segment.
How do you interpret ionis operations — segment reporting other item amount?
Large fluctuations may indicate one-time events that distort underlying operational performance.
How does ionis operations — segment reporting other item amount compare across companies?
Comparable to other operating income/expense or non-recurring items at peer companies.